1.Vincent, JL, Bihari, DJ, Suter, PM, et al.The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of infection in Intensive Care (EPIC) Study: EPIC International Advisory Committee. JAMA 1995;274:639–644.
2.Richards, MJ, Edwards, JR, Culver, DH, Gaynes, RP. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crif Care Med 1999;27:887–892.
3.Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470–485.
4.Safdar, N, Dezfulian, C, Collard, HR, Saint, S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005;33:2184–2193.
5.Danchaivijitr, S, Dhiraputra, C, Santiprasitkul, S, Judaeng, T. Prevalence and impacts of nosocomial infection in Thailand 2001. J Med Assoc Thai 2005;88(suppl 10):S1–S9.
6.Garrouste-Orgeas, M, Chevret, S, Arlet, G, et al.Oropharyngeal or gastric colonization and nosocomial pneumonia in adult intensive care unit patients: a prospective study based on genomic DNA analysis. Am J Respir Crit Care Med 1997;156:1647–1655.
7.Garcia, R. A review of the possible role of oral and dental colonization on the occurrence of health care-associated pneumonia: underappreciated risk and a call for interventions. Am J Infect Control 2005;33:527–541.
8.Bergmans, DC, Bonten, MJ, Gaillard, CA, et al.Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med 2001;164:382–388.
9.Kollef, M, Pittet, D, Sanchez Garcia, M, et al.A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia. Am J Respir Crit Care Med 2006;173:91–97.
10.Laggner, AN, Tryba, M, Georgopoulos, A, et al.Oropharyngeal decontamination with gentamicin for long-term ventilated patients on stress ulcer prophylaxis with sucralfate? Wien Klin Wochenschr 1994;106:15–19.
11.Rios, F, Maskin, B, Sanez, VA. Prevention of ventilator associated pneumonia by oral decontamination: prospective, randomized, double-blind, placebo controlled study. In: Program and abstracts of the American Thoracic Society International Conference (San Diego). 2005. C95. Poster 608.
12.DeRiso, AJ 2nd, Ladowski, JS, Dillon, TA, Justice, JW, Peterson, AC. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest 1996; 109:1556–1561.
13.Fourrier, F, Cau-Pottier, E, Boutigny, H, Roussel-Delvallez, M, Jourdain, M, Chopin, C. Effects of dental plaque antiseptic decontamination on bacterial colonization and nosocomial infections in critically ill patients. Intensive Care Med 2000;26:1239–1247.
14.Fourrier, F, Dubois, D, Pronnier, P, et al.Effect of gingival and dental plaque antiseptic decontamination on nosocomial infections acquired in the intensive care unit: a double-blind placebo-controlled multicenter study. Crit Care Med 2005;33:1728–1735.
15.MacNaughton, PD, Bailey, J, Donlin, N, Branfield, P, Williams, A, Rowswell, H. A randomised controlled trial assessing the efficacy of oral Chlorhexidine in ventilated patients. European Society of Intensive Care Medicine, 17th Annual Congress, Berlin, Germany. Intensive Care Med 2004;30(suppl):S5–S18.
16.Houston, S, Hougland, P, Anderson, JJ, LaRocco, M, Kennedy, V, Gentry, LO. Effectiveness of 0.12% Chlorhexidine gluconate oral rinse in reducing prevalence of nosocomial pneumonia in patients undergoing heart surgery. Am J Crit Care 2002;11:567–570.
17.Grap, MJ, Munro, CL, Elswick, RK Jr, Sessler, CN, Ward, KR. Duration of action of a single, early oral application of Chlorhexidine on oral microbial flora in mechanically ventilated patients: a pilot study. Heart Lung 2004;33:83–91.
18.Guideline for the Prevention of Healthcare-Associated Pneumonia, 2004. Atlanta, GA: Centers for Disease Control and Prevention, Healthcare Infection Control Practices Advisory Committee; 2004.
19.Chlebicki, MP, Safdar, N. Topical Chlorhexidine for prevention of ventilator-associated pneumonia: a meta-analysis. Crit Care Med 2007;35: 595–602.
20.Chan, EY, Ruest, A, Meade, MO, Cook, DJ. Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systematic review and meta-analysis. BMJ 2007;334:889–899.
21.Kola, A, Gastmeier, P. Efficacy of oral Chlorhexidine in preventing lower respiratory tract infections: meta-analysis of randomized controlled trials. J Hosp Infect 2007;66:207–216.
22.Koeman, M, van der Ven, AJ, Hak, E, et al.Oral decontamination with Chlorhexidine reduces the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 2006;173:1348–1355.
23.Denton, GW. Chlorhexidine. In: Block, SS, ed. Disinfection, Sterilization, and Preservation. 4th ed. Philadelphia, PA: Lea and Febiger; 1991.